Abstract:Background Autoinflammatory diseases are inherited disorders of the innate immune system caused by aberrant activation of the innate immune cells, primarily neutrophils and macrophages. Genetic studies have led to the identification of mutations in 12 genes responsible for various monogenic autoinflammatory diseases, however a significant number of mutation negative patients are sporadic cases or come from small families underpowered for linkage analysis. Objectives To identify disease causing mutation in a family with dominantly inherited inflammatory disease characterized by recurrent blistering skin lesions, pulmonary disease, arthralgia, inflammatory eye, bowel disease, absence of autoantibodies, and mild immunodeficiency manifested by recurrent sino-pulmonary infections. Methods Whole-exome sequencing was performed on three samples, including the affected father and daughter and unaffected mother. Exome data were filtered in more than 6000 exomes to exclude reported variants along with benign variants as determined by PolyPhen-2. A total of eight transcripts were identified as possible candidate genes. Results We confirmed a novel variant, p. S707Y, within the PLCG2 gene as the only de novo variant that was present in two affected and not present in four unaffected family members. PLCG2 encodes phospholipase Cγ2 (PLCγ2), an enzyme with a critical regulatory role in various immune and inflammatory pathways. The S707Y mutation is located in an autoinhibitory SH2 domain that is crucial for PLCγ2 activation. In vitro overexpression of the mutant S707Y protein and ex vivo experiments using patients’ leucocytes showed clearly enhanced PLCγ2 activity suggesting an increased intracellular signaling in the PLCγ2-mediated signaling pathway. Our finding that p. S707Y is hypermorphic mutation in PLCγ2 is further corroborated by animal studies that have implicated the critical role for PLCg2 in regulation of inflammation in mice. Two missense gain-of-function mutations in the murine phospholipase Cg2 (Plcg2) gene introduced by ENU mutagenesis, ALI5 and ALI14, lead to severe spontaneous inflammation and autoimmunity. Conclusions Recently, PLCG2 exon skipping mutations were reported in PLAID patients who present with cold-induced urticaria and immune dysregulation resulting in protein products with constitutive phospholipase activity but with reduced intracellular signaling at physiological temperature (ref). In contrast, we report here a missense PLCG2 mutation as a cause of a distinct inflammatory disease not provoked by cold temperatures, with different end-organ involvement and different cellular phenotype. Our result highlights the utility of exome sequencing technology in finding causal genes in nuclear families with dominantly inherited traits otherwise intractable by linkage analysis. References Ombrello, M.J., Remmers, E.F., Sun, G., Freeman, A.F., Datta, S., Torabi-Parizi, P., Subramanian, N., Bunney, T.D., Baxendale, R.W., Martins, M.S., et al. Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions. N Engl J Med. Disclosure of Interest None Declared

RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation

Clinical and functional spectrum of RAC2-related immunodeficiency

Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation

Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections

Case Report: Profound newborn leukopenia related to a novel RAC2 variant

Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant‐activating mutation

A Novel RAC2 Mutation Causing Combined Immunodeficiency

Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus

NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome

Autoinflammatory patients with Golgi-trapped CDC42 exhibit intracellular trafficking defects leading to STING hyperactivation

Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis

OP0174 Exome Sequencing Identifies a Hypermorphic Missense Mutation in the PLCG2 Gene As the Cause of a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency

Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents

Clinical heterogeneity of NLRP12-associated autoinflammatory diseases

Low-ratio somatic NLRC4 mutation causes late-onset autoinflammatory disease

Retention of ES cell-derived 129S genome drives NLRP1 hypersensitivity and transcriptional deregulation in Nlrp3tm1Flv mice

Somatic RAP1B gain-of-function variant underlies isolated thrombocytopenia and immunodeficiency

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis

Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus

Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function